Theravance Biopharma (TBPH) Net Equity Issued and Repurchased (2015 - 2025)

Theravance Biopharma's (TBPH) quarterly Net Equity Issued and Repurchased came in at $20000.0 in Q1 2025, down 33.33% on a QoQ basis from $30000.0 in Q4 2024.

Theravance Biopharma (TBPH) Net Equity Issued and Repurchased (2015 - 2025) Analysis & Trends

Theravance Biopharma (TBPH) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $20000.0 in Q1 2025.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $20000.0 in Q1 2025; TTM through Dec 2025 was $20000.0, a 63.64% decrease from a year earlier, with the FY2025 full-year figure at $20000.0, down 79.8% from the prior year.
  • Net Equity Issued and Repurchased for Q1 2025 stood at $20000.0, down from $30000.0 in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for TBPH reached as high as $30000.0 in Q4 2024 and fell as low as $20000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 141.90 Mn
10 Theravance Biopharma 864.82 Mn 470.15 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 20,000.00
Mar 31, 2025 20,000.00
Dec 31, 2024 30,000.00
Dec 31, 2024 30,000.00
Sep 30, 2024 25,000.00
Sep 30, 2024 25,000.00
Mar 31, 2020 139.92 Mn
Mar 31, 2020 139.92 Mn
Dec 31, 2016 107.79 Mn
Dec 31, 2016 107.79 Mn
Sep 30, 2016 17,000.00
Sep 30, 2016 17,000.00
Jun 30, 2016 117.42 Mn
Jun 30, 2016 117.42 Mn
Mar 31, 2016 27.80 Mn
Mar 31, 2016 27.80 Mn
Dec 31, 2015 51.76 Mn
Dec 31, 2015 51.76 Mn
Sep 30, 2015 -48,000.00
Sep 30, 2015 -48,000.00